Viewing Study NCT02487069


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-01-02 @ 7:45 PM
Study NCT ID: NCT02487069
Status: COMPLETED
Last Update Posted: 2020-03-05
First Post: 2015-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Sponsor: Nanfang Hospital, Southern Medical University
Organization:

Study Overview

Official Title: Allogeneic Stem Cell Transplantation With Alternative Donor in Treatment of Hematologic Malignancy
Status: COMPLETED
Status Verified Date: 2019-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to compare the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) from matched sibling donor (MSD),matched unrelated donor (MUD) and haploidentical related donors(HRD) in the treatment of hematologic malignancy.
Detailed Description: Currently, allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only curative therapy for a majority of malignant hematologic diseases, especially acute leukemia. HSCT from MSD offers the best results for these diseases, but lack of this donor resource has restricted its wide application. HSCT from MUD provides another option, but MUDs still cannot satisfy all patients due to unsuccessful donor searches. Almost all patients have an available related donor with whom they share a single HLA haplotype (ie, haploidentical related donor), and it owns the advantage of immediate availability, especially for those who urgently need transplantation.The results of transplantation from HRD have improved significantly over the past few years. However, the results from such haploidentical transplantation have not formally been compared with those of transplantation in patients contemporaneously using MSDs and MUDs for hematologic malignancy.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: